Glycoprotein GPNMB Is A Possible Biomarker For Parkinson’S Disease Risk
![](./upload/news/image_1660849812_53874291.jpg)
Computational, cell biological, and human tissue-based studies establish GPNMB as a risk gene and potential therapeutic target for Parkinson's Disease (PD), researchers report.